AspenBio Pharma Forms Medical Advisory Board for AppyScore TM …
The News Review:
- AspenBio Pharma Forms Medical Advisory Board for AppyScore TM …
- Automated ‘Artificial Pancreas’ Controls Blood Glucose Levels in …
- ChemGenex’s macetaxine Kills Leukemic Stem Cells in Human CML Models
- Angiotech Pharmaceuticals announces FDA 510(k) clearance of the …
AspenBio Pharma Forms Medical Advisory Board for AppyScore TM …
Market Wire (press release)
Wolf MD is the Bob and Betty Kelso Distinguished Chair in Burnand Trauma Surgery Vice Chairman for Research and Professor in theDepartment of Surgery at the University of Texas Health Science Center atSan Antonio (UTHSCSA). He serves as Chair for the Institutional ReviewBoard UTHSCSA. He is Burn Surgeon and Chief of Clinical Research at theUnited States Army Institute of Surgical Research at Fort Sam Houston andPediatric Burn Program Director at University Hospital. Wolf receivedhis medical degree from UTMB Galveston and completed his post graduatetraining at the University of Missouri-Kansas City and at Shriners Hospitalfor Children in Galveston. Wolf has previously held the position ofDirector of the US Army Institute of Surgical Research Burn Center atBrooke Army Medical Center and Assistant Chief of Staff at ShrinersHospital for Children.
Automated ‘Artificial Pancreas’ Controls Blood Glucose Levels in …
PR Newswire (press release)
ther researchers in the study included Dr. Eyal Dassau senior investigator and Dr. Benyamin Grossman both of Doyle’s group; and Sansum’s Dr. Lois Jovanovic CE and Chief Scientific fficer and Dr. Howard Zisser Director of Clinical Research. The research is part of the artificial pancreas project which is funded by the Juvenile Diabetes Research Foundation and is being conducted by an international group of diabetes research centers. The project’s first goal is to integrate an insulin pump and continuous blood glucose monitor to closely replicate a healthy pancreas for patients with type 1 diabetes–patients whose pancreases no longer produce insulin which is used by the body to control blood glucose levels.
ChemGenex’s macetaxine Kills Leukemic Stem Cells in Human CML Models
Business Wire (press release)
ChemGenex?s macetaxine Kills Leukemic Stem Cells in Human CML Models. css to create the news presentation used by BW.
Related from Gxy988: Chinese researchers find way to make pig stem cells
Angiotech Pharmaceuticals announces FDA 510(k) clearance of the …
PR Newswire (press release)
PE is the sudden blocking of an artery of the lung (pulmonary artery) by a collection of solid material brought through the bloodstream (embolus) – usually a blood clot (thrombus) or other foreign material. PE occurs when these clots break loose and “embolize” to block pulmonary blood vessels in the lungs. According to clinical research if left untreated PE has a mortality rate of 30%. Emboli dislodgement can be caused by peripheral vascular disease (PVD) severe deep vein thrombosis (DVT) trauma and prolonged immobilization often following a major surgical procedure. Forward Looking Statements ————————–Statements contained in this press release that are not based on historical fact including without limitation statements containing the words “believes” “may” “plans” “will” “estimates” “continues” “anticipates” “intends” “expects” and similar expressions constitute “forward-looking statements” within the meaning of the U. Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of applicable Canadian securities laws.
Written by admin on June 8th, 2009 with
no comments.
Read more articles on News.